Neoadjuvant therapy plays an increasingly important role in the multidisciplinary management of gastrointestinal cancers.
Neoadjuvant therapy (NAT) for early breast cancer was first introduced in the 1980s to downstage large, inoperable tumors, ...
A nationwide DMP for HTN in Austria leveraging telemedical tools is both feasible and urgently needed. Key success factors include clear inclusion criteria, technology access, comprehensive training, ...
Recent data presented at ASCO 2025 highlighted important advances in the treatment of ovarian cancer. The results of three ...
Dr. Sarah Temkin ist Regisseurin und Produzentin von 1001 Cuts. Als gynäkologische Onkologin mit über zwanzig Jahren ...
Effective immunomodulation of T-cell responses is critical in treating both autoimmune diseases and cancer. Our previous studies have demonstrated that secretomes derived from control or ...
HLH is a rare disease with an estimated yearly incidence (equivalent to the prevalence) of 0.1/10,000 when accounting for both primary and secondary forms (Henter et al. 1991; Meeths et al. 2011). The ...
Die Aorta erzählt ihre eigene Geschichte – von kindlicher Reinheit über die ersten molekularen Irritationen bis hin zum ...
Esophageal cancer poses a major health concern in the US, representing 1% of all cancer diagnoses and 2.6% of cancer-related deaths, with an estimated 21,560 new cases and 16,120 deaths in 2023 [ 1 – ...
Oral therapy options in oncology are increasingly valued for their convenience, reduced need for intravenous access, and ...
Internationale evidenzbasierte Abklärungsalgorithmen bei Kleinwuchs betonen die Wichtigkeit von Körpermessdaten: Nicht ein ...
Zur Datenerhebung wurden leitfadengestützte, halbstrukturierte Interviews durchgeführt. Der Interviewleitfaden wurde entlang thematischer Bereiche aufgebaut, die jeweils mit einer einleitend offenen F ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback